Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

The approach relies on “reprogramming” cells to a younger state. It’s one of many strategies being explored by biotech ...

First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

The government regards human aging not simply as a natural phenomenon but as a treatable disease, and has officially launched ...

In many ways, these are the best of times for Silicon Valley’s buzziest crop of longevity startups and their pursuit of drugs ...

Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our ...

The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...